Targeting EZH2 as cancer therapy
Authors:
Open Access
- 13 February 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 170 (1) , 1-4
Abstract
Enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of polycomb repressive complex 2 (PRC2) that mediate repression of target genes by trimethylation of Lys27 in histone 3 (H3K27me3). Given the reported roles of EZH2 in cancer, it is perhaps not surprising that targeting EZH2 in cancer therapy has become a hot research topic. Indeed, different types of EZH2 inhibitors are currently under development and are being evaluated by clinical trials. Recently, Murashima et al. identified NPD13668, a novel EZH2 inhibitor, by using a cell-based high-throughput screening assay. NPD13668 inhibited EZH2 methyltransferase activity, and repressed cell growth in multiple cancer cell lines, indicating a potential role for this compound in cancer treatment. In this review, we will focus on the current knowledge regarding the biological significance of PRC2 and H3K27me, and the recent advances in developing and testing drugs that target PRC2.Keywords
Funding Information
- KAKENHI (18H02681)
- Ministry of Education, Culture, Sports, Science, and Technology of Japan
This publication has 32 references indexed in Scilit:
- The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expressionGenes & Development, 2013
- Regulation of chromatin by histone modificationsCell Research, 2011
- The Polycomb complex PRC2 and its mark in lifeNature, 2011
- Histone H3K27ac separates active from poised enhancers and predicts developmental stateProceedings of the National Academy of Sciences of the United States of America, 2010
- Combinatorial patterns of histone acetylations and methylations in the human genomeNature Genetics, 2008
- High-Resolution Profiling of Histone Methylations in the Human GenomeCell, 2007
- Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cellsGenes & Development, 2007
- Polycomb Group Proteins Ring1A/B Link Ubiquitylation of Histone H2A to Heritable Gene Silencing and X InactivationDevelopmental Cell, 2004
- Role of histone H2A ubiquitination in Polycomb silencingNature, 2004
- Role of Histone H3 Lysine 27 Methylation in Polycomb-Group SilencingScience, 2002